http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020257952-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1023880af10dbe26a57dfb1cb687f92d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddf4ba970a43470e89b00a6c97d34684
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac003efc03a8886e71c5636d2160096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c034960893c0c04defd96a4b6e74a9ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b055cccc3e323e0d50f18a2ee7f4a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce6beaeed9696ad21d78a1b69f8cb20b
publicationDate 2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020257952-A1
titleOfInvention Antiproliferative effect of agarophyton chilensis extract in prostate cancer
abstract The invention relates to a pharmaceutical composition of Agarophyton chilensis extract which has an antiproliferative effect on prostate cancer and comprises: a) from 0.1% to 90% of an Agarophyton chilensis oleoresin with the main components of palmitic acid, arachidonic acid, oleic acid, stearic acid, myristic acid, linoleic acid; and b) from 10% to 99.9% of formulation excipients and auxiliaries for different pharmaceutical forms. The invention also relates to the use thereof for preparing a drug for treating or preventing prostate cancer and other hyperproliferative states of prostate tissue cells.
priorityDate 2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014186913-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3005573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10258

Total number of triples: 51.